Dawa za Ubora J&A
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of State has issued a Justification for Other Than Full and Open Competition (J&A) for the Dawa za Ubora (DzU) activity. This J&A supports a non-competitive, two-year extension of contract 72061521C00003 with the Mission for Essential Drugs and Supplies (MEDS) to ensure the uninterrupted continuation of life-saving HIV/AIDS services and commodity distribution in Kenya. This action is critical during the ongoing transition of HIV programming oversight from USAID to the Department of State.
Scope of Work
This extension ensures the continuity of vital services, including:
- Warehousing and distribution of U.S. Government-procured HIV commodities (antiretroviral therapy, HIV tests, viral load test reagents, early infant diagnosis test reagents).
- Maintaining uninterrupted care for approximately 1.3 million HIV-positive individuals in Kenya.
- Maintaining the integrity and security of the supply chain for USG-procured commodities.
Contract Details
- Contract Number: 72061521C00003
- Contractor: Mission for Essential Drugs and Supplies (MEDS)
- Original Period of Performance: Expires June 28, 2026
- Proposed Extension Period: June 29, 2026, through June 28, 2028 (2-year extension)
- Estimated Spend: Approximately [Amount Redacted] over the extension period, absorbed within the existing contract ceiling.
- Contract Type: Extension of an existing contract.
- Product/Service Code: R408 (Program Management/Support Services)
Justification & Authority
The non-competitive extension is justified under 40 U.S.C. 113, as implemented by AIDAR 706.302-70(b)(3)(ii) and FAR 6.303-2. The authority cites that full and open competition would impair foreign assistance objectives, specifically for countries, regions, projects, or programs where USAID (now DOS) makes a formal determination that compliance with full and open competition procedures would impair foreign assistance programs. This is substantiated by an Expedited Procedures Package (EPP) and a Determination & Findings (D&F) under the HIV/AIDS EPP.
Eligibility / Set-Aside
This is a sole-source extension and does not involve a set-aside.
Submission & Evaluation
This document is a justification for other than full and open competition, not a solicitation. Therefore, no proposal submission or evaluation criteria are applicable at this stage. A competitive process is planned for future requirements after the transition is complete.
Additional Notes
MEDS has a proven track record, having delivered over $327 million in health commodities to 10,268 health facilities in Kenya. The extension aligns with the "America First Global Health Strategy" and supports continuity of care during a complex transition period. The Contracting Officer has determined the anticipated cost to be fair and reasonable.